RESUMEN
Objective To review the drug therapies for benign prostatic hyperplasia (BPH) and provide a reference for clinical individualized medication regime.Methods The mechanisms and clinical indications of commonly used BPH medications and some new drugs were discussed.The challenges for BPH therapies were also explored.Results α-receptor inhibitors and 5α-reductase inhibitors have the best effect for BPH.Surgery is needed for the BPH patients who are not responsive to the drug therapy.Conclusion Individualized medication programs reduce the medication waste and give patients the best treatment options.
RESUMEN
Objective:To analyze the utilization and tendency of oral hypoglycemic agents in some hospitals of Wuhan from 2010 to 2012. Methods:The relative data of oral hypoglycemic agents used in 32 hospitals of Wuhan area during 2010-2012 were analyzed using consumption sum, DDDs and defined daily dose as the indices. Results:The consumption sum of oral hypoglycemic agents was increased year after year;acarbose and gliclazide were widely used and occupied front places among the drugs. However, the percent-age of traditional Chinese medicine used for decreasing blood sugar was declined. Conclusion:During 2010-2012, the DDDs value and the consumption sum of oral hypoglycemic agents in Wuhan area are stable and normal, and the application will be further developed.